BMO Capital Markets adjusted its outlook on Ingredion shares (NYSE:INGR), reducing the price target to $133 from $147, while maintaining a Market Perform rating. The revision follows Ingredion's ...

Co. Inc. (NYSE:MRK), reducing the pharmaceutical giant's price target from $105.00 to $96.00, while keeping a Market Perform rating on the stock. Analysts at BMO Capital cited a decrease in confidence ...

BMO Capital lowered the firm’s price target on FMC (FMC) to $50 from $62 and keeps a Market Perform rating on the shares after its Q4 results ...

BMO Capital Markets has recently initiated Aflac Inc (AFL) stock to Market Perform rating, as announced on January 23, 2025, according to Finviz. Earlier, on October 9, 2024, TD Cowen had initiated ...

BMO Capital analyst Bhavesh Lodaya lowered the firm’s price target on Olin (OLN) to $34 from $44 and keeps a Market Perform rating on the ...

Adtalem Global Education (NYSE:ATGE – Get Free Report) had its price objective lifted by equities researchers at BMO Capital Markets from $108.00 to $115.00 in a note issued to investors on ...

Franklin Resources (NYSE:BEN – Get Free Report) had its price objective boosted by analysts at BMO Capital Markets from $20.00 to $23.00 in a research report issued on Monday,Benzinga reports. The ...

In terms of valuation, 4D Molecular Therapeutics Inc’s market capitalization stands at $273.67 million. Market cap represents the total value of all outstanding shares and is a key indicator of a ...

The Canada-based bank dismissed the leader from its capital markets arm following a multimillion-dollar penalty to settle ...

BMO Capital Markets downgraded Everest Group to Market Perform due to deeper underwriting issues and a $1.7B reserve charge, ...

Canada’s facing a trade war with its largest partner, and it may send interest rates plunging. BMO Capital Markets wrote to ...

Galiano Gold downgraded by BMO Capital after revised five-year outlook for Asanko gold mine in Ghana, facing lower production ...